Skip to content

Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride

C23H27LiN4O2 — CID 173016688

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAClithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride
SMILESO=C(O)c1cccc2c1c(CNC1CN3CCC1CC3)nn2Cc1ccccc1.[H-].[Li+]
InChIInChI=1S/C23H26N4O2.Li.H/c28-23(29)18-7-4-8-21-22(18)19(25-27(21)14-16-5-2-1-3-6-16)13-24-20-15-26-11-9-17(20)10-12-26;;/h1-8,17,20,24H,9-15H2,(H,28,29);;/q;+1;-1
InChIKeyFDSRNYHRIDJFKG-UHFFFAOYSA-N
MW398.44 g/mol
LogP0.08
Rot. Bonds6

About Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride

Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride (PubChem CID 173016688) has the molecular formula C23H27LiN4O2 and a molecular weight of 398.44 g/mol. Its IUPAC name is lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride.

Molecular Properties

Compound NameLithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride
PubChem CID173016688
Molecular FormulaC23H27LiN4O2
Molecular Weight398.44 g/mol
Exact Mass398.23
IUPAC Namelithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride
SMILESO=C(O)c1cccc2c1c(CNC1CN3CCC1CC3)nn2Cc1ccccc1.[H-].[Li+]
InChIInChI=1S/C23H26N4O2.Li.H/c28-23(29)18-7-4-8-21-22(18)19(25-27(21)14-16-5-2-1-3-6-16)13-24-20-15-26-11-9-17(20)10-12-26;;/h1-8,17,20,24H,9-15H2,(H,28,29);;/q;+1;-1
InChIKeyFDSRNYHRIDJFKG-UHFFFAOYSA-N
XLogP0.08
TPSA70.39 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500398.44
LogP ≤ 50.08
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride?
The IUPAC name of Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride (CID 173016688) is lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride.
What is the SMILES notation for Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride?
The canonical SMILES for Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride is O=C(O)c1cccc2c1c(CNC1CN3CCC1CC3)nn2Cc1ccccc1.[H-].[Li+].
What is the InChIKey of Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride?
The InChIKey is FDSRNYHRIDJFKG-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H26N4O2.Li.H/c28-23(29)18-7-4-8-21-22(18)19(25-27(21)14-16-5-2-1-3-6-16)13-24-20-15-26-11-9-17(20)10-12-26;;/h1-8,17,20,24H,9-15H2,(H,28,29);;/q;+1;-1.
What are the key properties of Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride?
Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride has a molecular weight of 398.44 g/mol, XLogP of 0.08, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for Lithium;3-[(1-azabicyclo[2.2.2]octan-3-ylamino)methyl]-1-benzylindazole-4-carboxylic acid;hydride is sourced from PubChem (CID 173016688), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.